Nucleoside Solutions for Advanced Therapeutics
Unlock New Possibilities with Advanced Nucleoside Products
In collaboration with Kezx Biotechnology and Chengda Pharmaceutical, we offer a reliable and compliant supply chain solution to support your nucleoside-based therapies and diagnostic products.
The Growing Field of Nucleoside Medicine
Nucleoside-based products have rapidly become essential in modern therapeutics, notably in RNA and DNA-based treatments. As the foundation of many mRNA vaccines, RNAi drugs, and diagnostic reagents, nucleosides are pivotal in the development of:
- Therapeutic mRNA Vaccines: From the COVID-19 vaccine response to the latest advancements in personalized cancer therapies, mRNA technology is transforming healthcare
- RNA Interference (RNAi) Drugs: RNAi-based treatments are offering groundbreaking new options for rare diseases and targeted gene therapies.
- .Diagnostic Applications: Nucleosides play a critical role in COVID-19 detection reagents and are being integrated into other innovative diagnostic tools.
Despite the promise of these treatments, the nucleoside drug market is a highly regulated, competitive, and complex field. To succeed, companies need access to high-quality, GMP-compliant materials along with dependable, industry-focused expertise.
Why Partner with Exeris for Your Nucleoside Needs?
As a company with extensive experience in the pharmaceutical sector, Exeris understands the critical importance of quality, reliability, and compliance in nucleoside manufacturing. Through our collaboration with key industry leaders, we provide you with streamlined, dependable access to nucleoside products that support compliance and ease your market entry.
Our Partnership Network
• Kezx Biotechnology – A high-tech leader in R&D, Kezx specializes in nucleic acid raw materials and customized compounds. With a state-of-the-art R&D center in Shanghai, Kezx offers innovative solutions for your nucleoside development needs.
• Chengda Pharmaceutical – Operating a GMP-certified facility, Chengda handles all production, ensuring rigorous quality standards and regulatory compliance essential for nucleoside-based therapeutics.
• Exeris – Exeris manages exclusive sales and marketing, providing you with dedicated support and ensuring seamless integration of our nucleoside products into your development pipeline.
Our Nucleoside Product Portfolio
Our selection of nucleoside products is crafted to meet the needs of various advanced therapeutics, ensuring you have access to the materials you need to move your project forward:
- Nucleoside Monomers – Essential for oligonucleic acid drugs and mRNA vaccines
- Nucleotides – dNTPs for diagnostic reagents (COVID-19 detection) and NTPs for mRNA vaccines
- Modified Nucleosides – Designed for RNAi therapies and other targeted applications
- Ribonucleoside & Deoxy-ribonucleoside Triphosphates – Key raw materials for RNA and DNA synthesis
- Customized Oligonucleotides – Tailored to meet unique research and therapeutic requirements
Each product ican be manufactured under GMP standards, ensuring consistent quality, purity, and compliance with regulatory expectations.
Section 4: Streamlined Market Entry with Exeris
Exeris’s collaboration with Kezx and Chengda provides an end-to-end solution for companies entering the nucleoside drug market. By leveraging our partner network, we offer several distinct advantages:
- GMP Compliance: All products are manufactured under GMP guidelines, supporting regulatory compliance for your nucleoside-based products.
- Advanced Technology Access: With access to specialized technology from Kezx and high-standard production from Chengda, you receive precision-made nucleosides that meet the demanding requirements of modern therapeutics.
- Integrated Sales and Support: Exeris ensures smooth onboarding, streamlined logistics, and dedicated support to address your questions and keep your projects moving forward.
Learn More About Exeris’s Nucleoside Offering
At Exeris, we are committed to supporting your innovation in the nucleoside sector with reliable partnerships, GMP-certified production, and advanced R&D capabilities. Our goal is to make your journey into the nucleoside market as seamless and efficient as possible.
“Get in touch with us to discuss how our nucleoside products can support your development pipeline and help you navigate the complexities of the nucleoside market.”